Pair Name | Pterostilbene, Sunitinib | ||
Phytochemical Name | Pterostilbene (PubChem CID: 5281727 ) | ||
Anticancer drug Name | Sunitinib (PubChem CID: 5329102 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Pterostilbene, Sunitinib | |||
Disease Info | [ICD-11: 2B72] | Gastric cancer | Investigative | |
Biological Phenomena | Induction-->Oxidative Stress | |||
Gene Regulation | Down-regulation | Expression | PDZD8 | hsa118987 |
In Vitro Model | TMK-1 | Gastric adenocarcinoma | Homo sapiens (Human) | CVCL_4384 |
MKN74 | Gastric tubular adenocarcinoma | Homo sapiens (Human) | CVCL_2791 | |
In Vivo Model | Subcutaneous tumor models were established by inoculating cancer cells (MKN74: 5×10⁶ per mouse, TMK-1: 1×107 per mouse) into the scapular subcutaneous tissues of nude mice on Day 0. | |||
Result | PDZD8 may be a newly discovered off-target for SUN, and that the combined use of PTE with SUN significantly promotes antitumor activity in gastric cancer cell lines. The combined use of SUN and PTE might be a new molecular-targeted therapy for gastric cancer. |
No. | Title | Href |
---|---|---|
1 | Sunitinib and Pterostilbene Combination Treatment Exerts Antitumor Effects in Gastric Cancer via Suppression of PDZD8. Int J Mol Sci. 2022 Apr 4;23(7):4002. doi: 10.3390/ijms23074002. | Click |